The purpose


The purpose of the foundation is to promote human health and better life, primarily in Sweden, but in other countries as well. 

The promotion of the purpose should preferably be through contributions to prevent and combat cancer diseases, to treat and care for cancer patients and to support cancer research.

The purpose of the foundation may also be furthered through other research,  education, care, social relief work and other activities that directly or indirectly promote human health and better life.

 

 

 

The working methods


The foundation will actively source research projects and other projects that are supported by the foundations ordinance. Stiftelsen Cancera respects your privacy and will protect all data which we process about you. All personal data are processed in accordance with applicable data protection laws. Please read our information sheet for more details about this.

Grants awarded

The foundation has awarded the following grants.

 

In 2019

SEK 2,000,000 to Associate Professor Kristina Lundberg at the Faculty of Engineering at Lund University for the project “Tumor-infiltrating immune cells and their role within new immuno-oncological therapies”. 

The need of identifying new target structures that can kick-start an effective immune system against tumor cells is enormous. After receiving an earlier grant allowing the start-up of analyzing immune cells in tumor environment, a new grant will enable the development of analyzing additional cell types. 

SEK 1,500,000 to Professor Håkan Axelson at Lund University for the project “New methods for diagnosis of renal cancer”.

The purpose of the project is, by developing new tools for the diagnosis of renal cancer, to determine the type of cancer as well as the aggressivity of it through a simple blood test, which  will improve the prognosis of many patients. 

SEK 2,000,000 to Professor Malin Lindstedt at Lund University for the project “Immunotherapy for head and neck cancer”. 

The occurrence of tonsillar cancer is increasing and there is a great need of new treatments. The purpose of this project is to design new immunotherapeutic treatment that will activate the patients’ own immune cells to develop an anti-tumor response. In turn, this will improve the patients’ chance of survival. The project will also identify new prognostic and diagnostic biomarkers for head and neck cancer. 

SEK 2,000,000 to Professor Sara Ek at the Faculty of Engineering at Lund University for the project “Precision medicine made possible through spatial cellular and molecular analysis of cancer and immune cells in tumors”. 

Molecular basis for precise diagnostics and optimal treatments will revolutionize how we diagnose and treat complex diseases in the future. The digital spatial profiling technology allows such molecular data being obtained from patient samples on a routine basis. This will provide new opportunities to choose better treatments which in turn will give patients an increased chance of survival. 

SEK 2,000,000 to Doctor Leena Liljedahl at Lund University for the project “Advanced diagnostics of ovarian cancer increases chances of survival”.

The goal with this project is to identify blood-based biomarkers using mass spectrometry, for an improved diagnosis. The diagnosis will, at an early stage, separate ovarian cancer from benign and fluid filled cysts, which will result in the right patient getting specialized care and an increased chance of survival. 

SEK 20,000,000 to Professors Carl Borrebaeck at Lund University, George Coukos at University of Lausanne, Douglas Hanahan at Swiss Federal Institute of Technology Lausanne and Kristian Pietras at Lund University for the project ”Advancing Innovative Cancer Therapies”. 

The overall goals of the project are to develop innovative technologies that will enable significant process in personalized cancer therapy, to pursue the development of research tools and methodologies that will allow discovery of new cancer treatments and to continue promoting collaborations between Swiss Cancer Center Leman and Lund. To reach these goals the project will work with advancing antibody and chimeric antigen receptor T-cell therapy for tumors and work with innovative bioengineering technologies. The project will also focus on continuing the successful collaboration in targeting endocrine therapy resistance in luminal tumors and in exploiting new therapeutic vulnerabilities in triple-negative breast cancer. 

SEK 60 000 to Skåne University Hospital for the project called “A positive experience in conjunction with examination and treatment” under the direction of Head of Unit Kajsa Svärdebrandt. 

The purpose of this project is to give children and youths in treatment a more positive experience through installation of LED-monitors. The monitors create an illusion of skylights in the examination rooms. The aim is to create an environment that will improve the experience in the examination rooms as well as recovery. 

SEK 100 000 to Skåne University Hospital for the project called ”An inspiring care environment for children and youths at hospitals” under the direction of Head of Unit Ann Elmqvist Fridh.

There is a great need to improve the environment in the often bare care rooms. Studies show a calming effect of animals and nature and through projections of live fish on the walls for example you can activate and distract the children so that their visit is more joyful. The grant covers costs for purchase and installation of projections. 

In 2018

 

SEK 2,000,000 to Associate Professor Kristina Lundberg at the Faculty of Engineering at Lund University for the project "Tumour-infiltrating immune cells and their role in new immuno-oncology therapies".

The need for new strategies to prompt an adequate immune response against tumour cells is enormous. By identifying and characterising new types of immune cells in solid tumours, the project will develop new ways to kick-start an immune response directed against the tumour cells. In this way, we can make it possible for more patients to benefit from the powerful and long-term effects achieved with this new type of drug. 
 

  

SEK 2,000,000 to Dr Ulrika Axelsson at the Faculty of Engineering at Lund University for the project  "A molecular fingerprint of psychological resilience".

The purpose of the project is to identify a biomolecular signature which correlates with the degree of psychological resilience in breast cancer patients. This will open entirely new strategies for cancer treatments.

EUR 35,000 to Centre Hospitalier du Luxembourg, Department General and Minimally Invasive Surgery for the project "Comparative study of prognostic markers in colorectal cancer" Under the supervision of Dr Martine Goergen-Azagra and Silviu-Tiberiu Makkai-Popa.

The aim of the project is to collect, analyse, and compare different factors which have an impact on the cancer tumour's prognosis, with the goal of optimising the treatment of cancer patients.

SEK 2,000,000 to Professor Kristian Pietras and Dr Alexander Pietras at Lund University for their project "Contribution of the tumour microenvironment to aggressive tumour growth and treatment resistance".

The aim of the project is to understand the mechanisms underlying treatment resistance and tumour progression in brain tumours, with the goal of finding new therapeutic targets in the tumour's microenvironment. 

SEK 2,000,000 to Professor Sara Ek at the Faculty of Engineering at Lund University for the project "Early diagnosis of lung cancer".

Diagnosis of lung cancer at an early stage could save lives by means of surgical treatment. The possibilities of introducing digital tools to monitor early symptoms of lung cancer means that there is an absolute need for screening tools to meet the need to follow up on early symptoms of, among others, smokers. The goal of the project is to produce non-invasive, specific, and cost-efficient diagnostic tools which can complement current screening tools. 

Board


Ida Järvegren, President

Bengt Johansson, Member

Andreas Klow, Member

Frans Henrik Kockum, Member